Skip to main content

Table 3 Significant differences between children/adolescents with good response versus those with poor response to pharmacological treatment

From: Health care and societal costs of the management of children and adolescents with attention-deficit/hyperactivity disorder in Spain: a descriptive analysis

 

Good responders

(n = 139)

Poor responders

(n = 97)

P-value

Characteristics of the disease, mean (SD)

Current level of functioning (CGAS)

78.6 (12.9)

67.9 (16.3)

<0.0001

Lowest CGAS score during the previous year

58.5 (14.2)

67.9 (16.3)

0.001

Current severity, n (%)

Moderately-severely ill

36 (25.9)

63 (64.9)

<0.0001

Comorbidities, n (%)

Oppositional defiant disorder

20 (14.4)

27 (27.8)

0.01

Other conduct disorders

7 (5.0)

8 (8.2)

0.40

Anxiety

21 (15.1)

24 (24.7)

0.07

Addictions

1 (0.7)

4 (4.1)

0.16

Impact on social functioning, n (%)

Bad relationship with friends

1 (0.7)

15 (16.7)a

<0.0001

Bad relationship with family

7 (5.0)

22 (22.7)

<0.0001

  1. an = 90
  2. CGAS Children’s Global Assessment Scale, SD standard deviation